Lagoda Investment Management, L.P. Regeneron Pharmaceuticals, Inc. Transaction History

Lagoda Investment Management, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $54,323 - $64,177	-146 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $19.2 Million - $23.1 Million	-57,285 Reduced 99.75%	146 $55,000
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $894,353 - $1.04 Million	-2,547 Reduced 4.25%	57,431 $23.2 Million
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $1.9 Million - $2.31 Million	-6,682 Reduced 10.02%	59,978 $20.7 Million
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $720,701 - $898,605	2,282 Added 3.54%	66,660 $23 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $3.11 Million - $4.07 Million	8,661 Added 15.54%	64,378 $24.2 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $24 Million - $28.1 Million	55,717	55,717 $24.9 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Lagoda Investment Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Lagoda Investment Management, L.P. with notifications on news.